Journal of Clinical Endocrinology & Metabolism, Vol 70, 1247-1253, Copyright © 1990 by Endocrine Society

ARTICLES

Disproportionately elevated proinsulin in Pima Indians with noninsulin- dependent diabetes mellitus

MF Saad, SE Kahn, RG Nelson, DJ Pettitt, WC Knowler, MW Schwartz, S Kowalyk, PH Bennett and D Porte Jr
Diabetes and Arthritis Epidemiology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85014.

Fasting serum total immunoreactive insulin (IRI), true insulin, and true proinsulin (PI) were measured in 169 Pima Indians. The relationship of these variables to glucose tolerance, obesity, and parental diabetes was studied. Seventy-seven subjects had normal glucose tolerance, 46 had impaired glucose tolerance (IGT), and 46 had noninsulin-dependent diabetes mellitus (NIDDM) by WHO criteria. In subjects with normal glucose tolerance, the geometric mean ratio of PI to IRI (PI/IRI) was 10.8% (arithmetic mean, 12.5%), similar to that reported in other ethnic groups with lower prevalence rates of NIDDM. Parental diabetes had no effect on PI/IRI. Obese persons (body mass index, greater than or equal to 27 kg/m2) with normal glucose tolerance had PI/IRI of 9.3% compared with 16.3% for the nonobese (P less than 0.001), and PI/IRI was negatively correlated with body mass index (r = - 0.34; P = 0.002). Proinsulin was disproportionately elevated in NIDDM (geometric mean PI/IRI, 19.9%; arithmetic mean, 23.6%), and the degree of elevation was related to the severity of hyperglycemia, but not the duration of diabetes. Subjects with IGT were more obese and had higher fasting plasma glucose (5.7 vs. 5.2 mmol/L; P = 0.025), true insulin (250 vs. 125 pmol/L; P less than 0.001), and PI concentrations (26 vs. 15 pmol/L; P less than 0.001) than those with normal glucose tolerance but similar mean PI/IRI (9.4 vs. 10.8%; P = 0.4). These findings indicate that Pima Indians with NIDDM have a disproportionate elevation of PI consistent with the hypothesis that beta-cell dysfunction associated with hyperglycemia leads to the release of proinsulin-rich immature granules.

This article has been cited by other articles:

				A. Borjesson and C. Carlsson Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations or interleukin-1{beta} J. Endocrinol., February 1, 2007; 192(2): 381 - 387. [Abstract] [Full Text] [PDF]

				C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF]

				R. Retnakaran, A. J.G. Hanley, M. Sermer, and B. Zinman The Impact of Insulin Resistance on Proinsulin Secretion in Pregnancy: Hyperproinsulinemia is not a feature of gestational diabetes Diabetes Care, November 1, 2005; 28(11): 2710 - 2715. [Abstract] [Full Text] [PDF]

				M. E. Roder and S. E. Kahn Suppression of Beta-Cell Secretion by Somatostatin Does Not Fully Reverse the Disproportionate Proinsulinemia of Type 2 Diabetes Diabetes, December 1, 2004; 53(suppl_3): S22 - S25. [Abstract] [Full Text] [PDF]

				R. L. Hull, G. T. Westermark, P. Westermark, and S. E. Kahn Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3629 - 3643. [Abstract] [Full Text] [PDF]

				M. Maliqueo, I. Atwater, R. Lahsen, F. Perez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of {beta}-cell dysfunction? Hum. Reprod., December 1, 2003; 18(12): 2683 - 2688. [Abstract] [Full Text] [PDF]

				M. Guldstrand, B. Ahren, and U. Adamson Improved beta -cell function after standardized weight reduction in severely obese subjects Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E557 - E565. [Abstract] [Full Text] [PDF]

				D. Chin, S. E. Oberfield, M. E. Silfen, D. J. McMahon, A. M. Manibo, D. Accili, and L. S. Levine Proinsulin in Girls: Relationship to Obesity, Hyperinsulinemia, and Puberty J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4673 - 4677. [Abstract] [Full Text] [PDF]

				C. C. Jensen, M. Cnop, R. L. Hull, W. Y. Fujimoto, S. E. Kahn, and the American Diabetes Association GENNID Study Gro {beta}-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S. Diabetes, July 1, 2002; 51(7): 2170 - 2178. [Abstract] [Full Text] [PDF]

				J.-Y. Oh, E. Barrett-Connor, and N. M. Wedick Sex Differences in the Association Between Proinsulin and Intact Insulin With Coronary Heart Disease in Nondiabetic Older Adults: The Rancho Bernardo Study Circulation, March 19, 2002; 105(11): 1311 - 1316. [Abstract] [Full Text] [PDF]

				N. G. Knowles, M. A. Landchild, W. Y. Fujimoto, and S. E. Kahn Insulin and Amylin Release Are Both Diminished in First-Degree Relatives of Subjects With Type 2 Diabetes Diabetes Care, February 1, 2002; 25(2): 292 - 297. [Abstract] [Full Text] [PDF]

				A. Fritsche, A. Madaus, N. Stefan, O. Tschritter, E. Maerker, A. Teigeler, H. Haring, and M. Stumvoll Relationships Among Age, Proinsulin Conversion, and {beta}-Cell Function in Nondiabetic Humans Diabetes, February 1, 2002; 51(90001): S234 - 239. [Abstract] [Full Text] [PDF]

				A. J. G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M. S. Wolever, J. Kwan, and B. Zinman Cross-Sectional and Prospective Associations between Abdominal Adiposity and Proinsulin Concentration J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 77 - 83. [Abstract] [Full Text] [PDF]

				S. E. Kahn The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058. [Full Text] [PDF]

				A. J.G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M.S. Wolever, J. Kwan, P. W. Connelly, and B. Zinman Cross-Sectional and Prospective Associations Between Proinsulin and Cardiovascular Disease Risk Factors in a Population Experiencing Rapid Cultural Transition Diabetes Care, July 1, 2001; 24(7): 1240 - 1247. [Abstract] [Full Text] [PDF]

				T. Laedtke, L. Kjems, N. Porksen, O. Schmitz, J. Veldhuis, P. C. Kao, and P. C. Butler Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E520 - E528. [Abstract] [Full Text] [PDF]

				M. E. Røder, R. S. Schwartz, R. L. Prigeon, and S. E. Kahn Reduced Pancreatic B Cell Compensation to the Insulin Resistance of Aging: Impact on Proinsulin and Insulin Levels J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2275 - 2280. [Abstract] [Full Text]

				H. Larsson and B. Ahrén Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2068 - 2074. [Abstract] [Full Text]

				K. Hostens, Z. Ling, C. Van Schravendijk, and D. Pipeleers Prolonged Exposure of Human {beta}-Cells to High Glucose Increases Their Release of Proinsulin during Acute Stimulation with Glucose or Arginine J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1386 - 1390. [Abstract] [Full Text]

				S. M. Haffner, R. D'Agostino Jr, L. Mykkanen, C. N. Hales, P. J. Savage, R. N. Bergman, D. O'Leary, M. Rewers, J. Selby, R. Tracy, et al. Proinsulin and Insulin Concentrations in Relation to Carotid Wall Thickness : Insulin Resistance Atherosclerosis Study Stroke, August 1, 1998; 29(8): 1498 - 1503. [Abstract] [Full Text] [PDF]

				R. L. Prigeon, S. E. Kahn, and D. Porte Jr. Effect of Troglitazone on B Cell Function, Insulin Sensitivity, and Glycemic Control in Subjects with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 819 - 823. [Abstract] [Full Text]

				M. P. Stern The Effect of Glycemic Control on the Incidence of Macrovascular Complications of Type 2 Diabetes Arch Fam Med, March 1, 1998; 7(2): 155 - 162. [Abstract] [Full Text] [PDF]

				M. E. Røder, D. Porte Jr., R. S. Schwartz, and S. E. Kahn Disproportionately Elevated Proinsulin Levels Reflect the Degree of Impaired B Cell Secretory Capacity in Patients with Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 604 - 608. [Abstract] [Full Text]

				R. P. Donahue, J. A. Bean, R. D. Donahue, R. B. Goldberg, and R. J. Prineas Does Insulin Resistance Unite the Separate Components of the Insulin Resistance Syndrome? : Evidence From the Miami Community Health Study Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2413 - 2417. [Abstract] [Full Text]

				P.-W. Wang, F. Abbasi, M. Carantoni, Y.-D. I. Chen, S. Azhar, and G. M. Reaven Insulin Resistance Does Not Change the Ratio of Proinsulin to Insulin in Normal Volunteers J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3221 - 3224. [Abstract] [Full Text] [PDF]

				J. P. Toyry, L. K. Niskanen, M. J. Mantysaari, E. A. Lansimies, S. M. Haffner, H. J.J. Miettinen, and M. I.J. Uusitupa Do High Proinsulin and C-Peptide Levels Play a Role in Autonomic Nervous Dysfunction? : Power Spectral Analysis in Patients With Non–Insulin-Dependent Diabetes and Nondiabetic Subjects Circulation, August 19, 1997; 96(4): 1185 - 1191. [Abstract] [Full Text]

				A. D. Kippen, F. Cerini, L. Vadas, R. Stocklin, L. Vu, R. E. Offord, and K. Rose Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay J. Biol. Chem., May 9, 1997; 272(19): 12513 - 12522. [Abstract] [Full Text] [PDF]

				M. P. Stern Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents? Ann Intern Med, January 1, 1996; 124(1_Part_2): 110 - 116. [Abstract] [Full Text]